Tag: engineering
-

Digital Neuroscience Companies Partner on AR/AI Diagnostics
Two companies creating digital technologies for neurological conditions are collaborating on augmented reality and artificial intelligence in diagnostics.
-

NIH Small Biz Grant Supports Uterine Health Diagnostic
A women’s health diagnostics developer is receiving funds for a non-invasive test analyzing menstrual fluids to detect the uterine disorder endometriosis.
-

New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-

Infographic – Simulated Clinical Trials Gain Traction
In 2021, 15 simulated or in silico trials, as they’re called, were underway, a rapid jump in this technique from the two trials reported 2018.
-

Whole Genome Sequencing Shown to Detect Neuro Disorders
An analysis of genetic database records indicates a class of neurological diseases can be detected by sequencing of a person’s entire genome.
-

Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.
-

Pharma Company Licenses Protein Delivery Hydrogel
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue.
-

Advanced Tech Venture Funds Raise $365 Million
Three venture capital investors specializing in robotics, artificial intelligence, and other advanced technologies raised $365 million for start-up financing.
-

University Lab Licenses Printed Kidney Tissue Process
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure.
-

Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.